The largest database of trusted experimental protocols

19 protocols using p3 flag cmv 10 vector

1

Lentiviral Plasmid Construction for SKA3 Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild-type and phosphorylation-site mutant SKA3 lentiviral expression plasmids were generated by inserting wild type or mutant SKA3 CDS fusion with a Flag tag sequence into the BamHI and XhoI sites of the lentiviral vector pLenti-puro (a gift from Ie-Ming Shih, Addgene plasmid # 39481). For SKA3-knockdown stable cell generation, three sgRNAs targeting SKA3 exon 1 were synthesized and inserted into the pSpCas9(BB)-2A-Puro vector (Addgene plasmid # 62988). shRNA constructs targeting the top 50 upregulated genes used for high-content screening and the negative-control construct were purchased from Sigma-Aldrich (Munich, Germany). Wild-type and phosphorylation-site mutant SKA3 transient expression plasmids were constructed by inserting the corresponding expression frame into p3×FLAG-CMV-10 vector (Sigma-Aldrich). PLK1, PTEN, and Ubiquitin (Ub) expression plasmids were generated by inserting coding sequence into pCMV-HA vector (Clontech). Luciferase reporter plasmid pGL4.10-SKA3 was generated by inserting the promoter sequence (+100 to −1000 relative to transcription start site) into pGL4.10 vector. Transfection was performed using Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol.
+ Open protocol
+ Expand
2

Generating LRRK2 Mutant Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression plasmids encoding full-length human LRRK2 (wild-type, K1906A, K1906M, D1994A, D1994N, A2016T, D2017A, G2019S, T2031S, S2032A, and T2035A) cloned in the p3×FLAG-CMV-10 vector (Sigma) were constructed as described previously [30] (link)–[32] (link). Following oligonucleotides were used as forward primers: 5′-gaagtggctgtggcgatttttaataaac-3′ for K1906A, 5′-gattatataccgaaacctgaaaccc-3′ for D1994N, 5′-catcattgcaaagattactgactacggcattg-3′ for A2016T, 5′-caaagattgctgcctacggcattg-3′ for D2017A, 5′-ggataaaatcatcagagggcac-3′ for T2031S, 5′-ggataaaaacagcagagggcac-3′ for S2032A, and the corresponding complementary sequences were used as reverse primers. Primers for other mutants were described previously [30] (link)–[32] (link).
+ Open protocol
+ Expand
3

Overexpression of Human CD77 Synthase

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CD77 synthase cDNA [23,24] was amplified by polymerase chain reaction and inserted into the p3 × FLAG-CMV10 vector (Sigma). U937 cells were pulsed with a Gene Pulser II Electroporation System (BIO-RAD) at 250 V and 950 μF in the presence of 50 μg of the expression vector. After recovery for 48 h, the cells were selected with 1 mg/ml G418.
+ Open protocol
+ Expand
4

Parkin Plasmid Constructs and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full-length GFP-HDAC6 was purchased from OriGene Technologies, and p3xFLAG-parkin WT (FLAG-parkin) plasmid was a gift from Dong Hyun Sohn (Pusan University, Korea). Four multiple domains of parkin were constructed by inserting the cDNA into the p3xFLAG-CMV10 vector. Briefly, the FLAG-parkin and its deletion mutants (1–3) were constructed by inserting cDNA into the p3×FLAG-CMV10 vector (Sigma) between EcoRI and EcoRV sites. The multiple domain site mutants (Mt1, Mt2, or Mt3) of parkin were generated using the full-length FLAG-parkin plasmid as the template (see Additional file 1: Table S1 for detailed information). For cell transfection of plasmids, the transfection mixture used to transiently transfect the described cell lines was based on a mixture of plasmid DNA and Lipofectamine 3000 transfection reagent, as described in the procedures (Thermo Fisher Scientific). Plasmid DNA and transfection reagent were dissolved in α-MEM (without additives) and incubated at room temperature for 30 min. The mixture was added dropwise into the cell culture dish and incubated for 24 h in HEK 293 cells or further cultured for 3 days (including M-CSF and RANKL) in RAW 264.7 cells at 37 °C under an atmosphere of 5% CO2.
+ Open protocol
+ Expand
5

Plasmid Construction of Kindlin-2 and Talin-H

Check if the same lab product or an alternative is used in the 5 most similar protocols
The construction of plasmid pFlag-Kindlin-2 and deletion mutants of Kindlin-2 has been previously reported (Wei et al., 2013 (link)). To generate Flag-Talin-H (1–433 aa) and CFP-Talin-H, DNA fragments encoding residues 1–433 of Talin were amplified by PCR and inserted into p3×Flag-CMV-10 vector (Sigma-Aldrich) and pECFP-C3 vector. To generate GFP-Kindlin-2, cDNA encoding full-length Kindlin-2 was amplified by PCR and inserted into pEGFP-C3 vector. All constructs were confirmed by DNA sequencing. Myc-Smurf1 WT, Myc-Smurf1-C699A, Flag-Smurf1, Flag-Smurf1-C699A, GFP-Smurf1, truncates of Smurf1, and HA-Ub were described previously (Lu et al., 2008 (link)). Point mutations of Kindlin-2 and Ub were generated using a Muta-direct mutagenesis kit (SBS; Genentech). All mutations were confirmed by DNA sequencing.
+ Open protocol
+ Expand
6

Generating Recombinant PPRV N and NCL Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PPRV N protein cDNA (GenBank accession no. HQ197753.1) was cloned into the mammalian expression vector p3 ×Flag-CMV10 vector (Sigma) with the EcoRI and KpnI restriction enzymes to generate the p3 ×Flag-N plasmid. The pHA-NCL plasmid encoding the NCL protein with a HA tag was obtained by cloning NCL cDNA (GenBank accession no.XM_012163051.2) into a pCMV-HA vector (Clontech). For prokaryotic expression of the glutathione S-transferase (GST)-tagged N protein, DNA encoding the N protein was subcloned into the pGEX-4T-1 vector (Invitrogen) with the EcoRI and NotI restriction endonucleases. Truncated mutants of NCL and PPRV N were generated from pHA-NCL and p3 ×Flag-N by conventional PCR (the primers will be made available upon request). All constructs were confirmed by sequencing (Sangon Biotech).
+ Open protocol
+ Expand
7

Eukaryotic Elongation Factor 1A Domains

Check if the same lab product or an alternative is used in the 5 most similar protocols
The swine eEF1A gene (GenBank accession no. NM_001097418.2) and its various domains were amplified by PCR and cloned into the pMyc vector (Clontech, Palo Alto, CA, USA) to generate pMyc-eEF1A, pMyc-eEF1A(1-333), pMyc-eEF1A(1-237), pMyc-eEF1A(238-462) and pCMV-Myc-eEF1A(201-333), respectively. The CSFV NS5A gene (GenBank accession no. EU497410.1) was amplified by PCR and cloned into the p3×Flag-CMV-10 vector (Sigma-Aldrich, ST. Louis, MO, USA) or pCMV-Myc to generate p3×Flag-NS5A or pMyc-NS5A. The primers for amplifying eEF1A and NS5A genes are listed in Table 1.
+ Open protocol
+ Expand
8

Regulation of Reg4 Expression in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Specific siRNAs targeting human Reg4 (siReg4-1 and siReg4-2) and non-targeting control siRNA (siCtrl) were designed and provided by Shanghai GenePharma Co., Ltd, China. The siReg4-1 sequences were 5′-AAGUGGCUAUCAGAGAAGCTT-3′ and 5′-GCUUCUCUGAUAGCCACUUTT-3′. The siReg4-2 sequences were 5′-GACAGAAGGAAGAAACUCATT-3′ and 5′-UGAGUU UCUUCCUUCUGUCTT-3′. The siCtrl sequences were 5′-UUCU CCGAACGUGUCACGUTT-3′ and 5′-ACGUGACACGUUCGGAG AATT-3′. For overexpression of Reg4 gene, its cDNA was amplified using polymerase chain reaction (PCR) and subcloned into the p3 × FLAG-CMV-10 vector (Sigma, St. Louis, MO, USA). The p3 × FLAG vector was used as control. All transfections were performed using Lipofectamine3000 reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. After transfection for 24 hours, the alterations of Reg4 expression were evaluated by Western blot and RT-qPCR.
+ Open protocol
+ Expand
9

Generation of Inducible Atf6 Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The coding region of p50Atf6 was cloned by RT-PCR and inserted into the p3 × FLAG-CMV-10 vector (Sigma-Aldrich, St-Louis, MO) to intracellularly express N-terminal Flag-tagged p50Atf6 fusion protein. The shRNA for Atf6 mRNA expression vector was constructed using the pSingle-tTS-shRNA vector (Clontech, Mountain View, CA) with an oligonucleotide targeting Atf6. Target sequence to construct an inducible shRNA expression vector for Atf6 using the pSingle-tTS-shRNA vector was as follows: 5′-TCG AGG CTC AGA CAT GAA GGC AGA TTC AAG AGA TCT GCC TTC ATG TCT GAG CTT TTT TAC GCG T-3′, where the target in indicated in bold underlined italic font. The resultant plasmid was designated as pSingle-tTS-Atf6-shRNA. Vectors were transfected with Xfect Transfection Reagent (Clontech).
+ Open protocol
+ Expand
10

Plasmids for Studying Protein Kinases and Deacetylases

Check if the same lab product or an alternative is used in the 5 most similar protocols
FLAG-UBR5 (#37188), HA-GSK3β (#14753), HA-GSK3β-S9A (#14754), and HA-GSK3β-K85A expression plasmids were from Addgene (USA). FLAG-AMPKα1 (CH805185), FLAG-SKP2 (CH896343), and FLAG-AKT1 (CH846646) were purchase from Vigenebio (Shangdong, China). SIRT7 and GSK3β deletion mutants were constructed into the p3× FLAG-CMV10 vector (Sigma). GST-tagged SIRT7 or SIRT7-S259A/Thr263A/Thr255A was constructed by cloning into pGEX-4T-3 (GE Healthcare). The other SIRT7 mutants were generated by the site-directed mutagenesis using the KOD-Plus-Neo DNA polymerase (TOYOBO). All plasmids were confirmed by DNA sequencing (Genewiz). Details of the primers used for the generation of these plasmids or other experiments are shown in Supplementary Table 2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!